Cellcept and Nuvigil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Nuvigil (armodafinil). Common drug interactions include dyspnoea among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Nuvigil. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Nuvigil?

Nuvigil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 23,669 Nuvigil users. Check the latest studies of Nuvigil.



On Jul, 14, 2026

31 people who take Cellcept and Nuvigil together, and have interactions are studied.

Cellcept and Nuvigil drug interactions.

What are the common drug interactions of Cellcept and Nuvigil, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Electrocardiogram st segment depression
  3. Feeling hot
  4. Fibromyalgia (a long-term condition which causes pain all over the body)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Insomnia (sleeplessness)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Pain in extremity
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Peripheral swelling

male:

  1. Death
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  4. Pruritus (severe itching of the skin)

What are the common drug interactions of Cellcept and Nuvigil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Weight decreased
  2. Obesity (having too much body fat)
  3. Therapeutic response unexpected
  4. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  5. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  6. Blood cholesterol increased
  7. Blood iron decreased
  8. Blood potassium decreased
  9. Device dislocation
  10. Dyspnoea (difficult or laboured respiration)

40-49:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Device dislocation
  3. Implant site infection
  4. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  5. Muscular weakness (muscle weakness)
  6. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  7. Pruritus (severe itching of the skin)

50-59:

  1. Blood cholesterol increased
  2. Blood iron decreased
  3. Blood potassium decreased
  4. Dyspnoea (difficult or laboured respiration)
  5. Electrocardiogram st segment depression
  6. Feeling hot
  7. Fibromyalgia (a long-term condition which causes pain all over the body)
  8. Hypersensitivity
  9. Hypertension (high blood pressure)
  10. Hypoaesthesia (reduced sense of touch or sensation)

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Death
  3. Hypersensitivity
  4. Hypertension (high blood pressure)
  5. Intervertebral disc degeneration (spinal disc degeneration)
  6. Mouth cyst (a fluid filled sac in mouth)
  7. Optic neuritis (optic nerve inflammation)
  8. Urinary retention (the inability to completely or partially empty the bladder)

What are the existing conditions these people have? *

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 32.26%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 12.90%
  3. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 4 people, 12.90%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 9.68%
  5. Drowsiness: 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Nuvigil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cellcept and Nuvigil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nuvigil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nuvigil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and armodafinil (the active ingredients of Cellcept and Nuvigil, respectively), and Cellcept and Nuvigil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: